UBC Announces Acquisition of MarketShare Movers
Acquisition of data-driven prescription drug benefit and affordability company will ”help patients overcome financial barriers to starting and staying on therapy.”
UBC (Blue Bell, PA) has announced that it has acquired MarketShare Movers (MSM), a data-driven prescription drug benefit and affordability company.
“This acquisition enriches what we can offer to our current and future clients, inclusive of adding a full-service co-pay offering,” said Nicole Hebbert, Senior Vice President, UBC Patient Access Services. “The MSM Team will bring a specific expertise in modeling affordability programs to achieve optimal access to patients.”
Kevin Kane, founder of MarketShare Movers, added, “Using MSM’s consultative approach and proprietary analytics, UBC will now partner with clients to design and implement advanced and integrated patient co-pay benefit programs. This allows our clients to leverage our analysis and track the ongoing, multi-tiered impact of each benefit design and gross to net.”
UBC said it looks forward to bringing these capabilities to its current and future clients through comprehensive insights-based approaches to co-pay and affordability programs.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
